Company / Total Assets
Janux Therapeutics, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.0B
FY2025
5-year range
$364.0M / $1.1B
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#84 of 216
Health Care
What the data says
At $1.0B, Janux Therapeutics, Inc.'s total assets ranks #84 of 216 in the Health Care sector. Total Assets has fluctuated over the past 6 years, ranging from $16M in FY2020 to $1.1B in FY2024.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +128.1%.
Improved from $380M to $1.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +40.1%
- 5-Year CAGR
- +128.1%
- 10-Year CAGR
- -
Sector benchmark
#84 of 216 in Health CareTop 39% of 216This company $1.0B Sector average $7.4B
▼
-86.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +128.1%, indicating consistent growth.
- In FY2025, total assets decreased 5.6% year-over-year.
- Ranks #84 out of 216 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | -5.6% |
| FY2024 | $1.1B | +179.0% |
| FY2023 | $380.4M | +4.5% |
| FY2022 | $364.0M | -4.2% |
| FY2021 | $379.8M | +2242.1% |
| FY2020 | $16.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026